Investigación

Leucemia y hemopatías pediátricas

Buscador de publicaciones

Publicaciones

  • Ruiz-Llobet A, Gassiot S, Sarrate E, Zubicaray J, Rives-Solà S, Suleman W and Berrueco R.

    Thrombin Generation Profile Using ST-Genesia after PEG-asparaginase in Pediatric Patients with Acute Lymphoblastic Leukemia

    THROMBOSIS AND HAEMOSTASIS . 124(10): 973-985.

    [doi:10.1055/a-2316-4547]

  • Pennesi E, Brivio E, Ammerlaan ACJ, Jiang Y, Van der Velden VHJ, Beverloo HB, Sleight B, Locatelli F, Brethon B, Rossig C, Engstler G, Nilsson A, Bruno B, Petit A, Bielorai B, Rizzari C, Rialland F, Rubio-San-Simón A, Sirvent FJB, Diaz-de-Heredia C, Rives-Solà S and Zwaan CM.

    Inotuzumab ozogamicin combined with chemotherapy in pediatric B-cell precursor CD22+ acute lymphoblastic leukemia: results of the phase IB ITCC-059 trial

    HAEMATOLOGICA . 109(10): 3157-3166. Nº de citas: 6

    [doi:10.3324/haematol.2023.284409]

  • Mingot-Castellano ME, Reguera-Ortega JL, Zafra Torres D, Hernani R, Lopez-Godino O, Guerreiro M, Herrero B, López-Corral L, Luna A, Gonzalez-Pinedo L, Chinea-Rodriguez A, Africa-Martín A, Bailen R, Martinez-Cibrian N, Balsalobre P, Filaferro S, Alonso-Saladrigues A, Barba P, Perez-Martinez A, Calbacho M, Perez-Simón JA, Sánchez-Pina JM and On Behalf Of The Spanish Group Of Hematopoietic Transplant And Cell Therapy Get.

    Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients

    Journal of Clinical Medicine . 13(17): . Nº de citas: 2

    [doi:10.3390/jcm13175117]

  • Juan-Ribelles A, Bautista F, Cañete A, Rubio-San-Simón A, Alonso-Saladrigues A, Hladun R, Rives-Solà S, Dapena JL, Fernández JM, Lassaletta Á, Cruz-Martínez O, Ramírez-Villar G, Fuster JL, de Heredia CD, García-Ariza M, Quiroga E, Del Mar Andrés M, Verdú-Amorós J, Molinés A, Herrero B, López M, Márquez C, Toboso M, Lendínez F, Sirvent JG, Tallón M, Rodríguez G, Acha T, Moreno L and Fernández-Teijeiro A.

    ECLIM-SEHOP: how to develop a platform to conduct academic trials for childhood cancer

    CLINICAL & TRANSLATIONAL ONCOLOGY . 26(9): 2351-2359.

    [doi:10.1007/s12094-024-03445-0]

  • Sánchez-Espino LF, Ivars M, Prat-Torres CS, Lavarino C, Gene-Olaciregui N, Rovira-Zurriaga C, Celis-Passini V, Miguel Bejarano Serrano and Baselga E.

    Single dominant lesion in capillary malformation-arteriovenous malformation (CM-AVM) RASA1 syndrome

    PEDIATRIC DERMATOLOGY . 41(5): 861-865.

    [doi:10.1111/pde.15598]

  • Velasco Puyó P, Tagarro A, Garcia-Obregon S, Villate Bejarano O, Moraleda C, Huerta Aragonés J, Bardón Cancho EJ, Faura A, Galán-Gómez V, Escobar Fernández L, Lendinez-Molinos F, Herrero Velasco B, Ureña Horno L, Domínguez-Pinilla N, Pascual Gazquez JF, Nova Lozano C, Osuna-Marco M, Marín-Cruz I, Gomez Pastrana I, Garcia de Andoin Barandiaran N, Gallego Mingo N, Portugal Rodríguez R, Cañete A, Pareja León M, Castrillo Bustamante S, Tallón García M, Gónzalez-Prieto A, Solé-Rodríguez M, González Cruz M, Soriano-Arandes A, Mota M, Pérez-Hoyos S, Moreno L and Astigarraga I.

    Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities

    PEDIATRIC BLOOD & CANCER . 71(8): .

    [doi:10.1002/pbc.31120]

  • Marco Sánchez JM, Bardón Cancho EJ, Benéitez D, Payán-Pernía S, Collado Gimbert A, Ruiz-Llobet A, Salinas JA, Sebastián E, Argilés B, Bermúdez M, Vázquez MÁ, Ortega MJ, López Rubio M, Gondra A, Uriz JJ, Morado M, Coll MT, López Duarte M, Baro M, Cervera Á, Recasens V, García Blanes C, Del Carcavilla MP, Tallon M, González Espín A, Olteanu Olteanu FC, González P, Del Mañú Pereira MM and Cela E.

    Haemoglobinopathies and other rare anemias in Spain: ten years of a nationwide registry (REHem-AR)

    ANNALS OF HEMATOLOGY . 103(8): 2743-2755. Nº de citas: 2

    [doi:10.1007/s00277-024-05788-8]

  • Benítez L, Castro-Barquero S, Crispi F, Youssef L, Crovetto F, Fischer U, Kameri E, Bueno C, Camós-Guijosa M, Menéndez P, Heinäniemi M, Borkhardt A and Gratacós E.

    Maternal Lifestyle and Prenatal Risk Factors for Childhood Leukemia: A Review of the Existing Evidence

    FETAL DIAGNOSIS AND THERAPY . 51(4): 395-410. Nº de citas: 1

    [doi:10.1159/000539141]

  • Wu JH, Pennesi E, Bautista F, Garrett M, Fukuhara K, Brivio E, Ammerlaan ACJ, Locatelli F, van der Sluis IM, Rossig C, Chen-Santel C, Bielorai B, Petit A, Starý J, Díaz-de-Heredia C, Rives-Solà S, O'Marcaigh A, Rizzari C, Engstler G, Nysom K, Rubio-San-Simón A, Bruno B, Bertrand Y, Brethon B, Rialland F, Plat G, Dirksen U, Sramkova L, Zwaan CM and Huitema ADR.

    Population Pharmacokinetics of Inotuzumab Ozogamicin in Pediatric Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Results of Study ITCC-059

    CLINICAL PHARMACOKINETICS . 63(7): 981-997. Nº de citas: 2

    [doi:10.1007/s40262-024-01386-z]

  • Bandini P, Borràs N, Berrueco R, Gassiot S, Martin-Fernandez L, Sarrate E, Comes N, Ramírez L, Hobeich C, Vidal F and Corrales I.

    Gaining Insights into Inherited Bleeding Disorders of Complex Etiology in Pediatric Patients: Whole-Exome Sequencing as First-Line Investigation Tool

    THROMBOSIS AND HAEMOSTASIS . 124(07): 628-640. Nº de citas: 1

    [doi:10.1055/s-0043-1778070]